Holman Division of Endocrinology, Diabetes & Metabolism Publications
Research conducted by NYU Langone’s Holman Division of Endocrinology, Diabetes, and Metabolism appears in leading academic and medical publications.
Medical Therapies of Cushing's Disease-Part 1
Endocrinology & metabolism clinics of North America. 2025 Dec ; 54:609-626
Medical Therapies of Cushing's Disease-Part 2
Endocrinology & metabolism clinics of North America. 2025 Dec ; 54:627-635
Association of Platelet Aggregation With Markers of Alzheimer Disease Pathology in Middle-Aged Participants of the Framingham Heart Study
Neurology. 2025 Nov 25; 105:e214314
Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas?
Pituitary. 2025 Nov 03; 28:123
Lifestyle intervention is more effective in high 1-hour post-load glucose than in prediabetes for restoring β-cell function, reducing ectopic fat, and preventing type 2 diabetes
Metabolism: clinical and experimental. 2025 Nov 03; 174:156430
One-hour plasma glucose defining stages of type 2 diabetes - The ELSA-Brasil study
Diabetes research and clinical practice. 2025 Nov ; 229:112916
Mortality in patients with dopamine agonist-treated hyperprolactinemia: a large matched-cohort study
Pituitary. 2025 Oct 22; 28:116
Extracellular Vesicles From Chylomicron-Treated Endothelial Cells Drive Macrophage Inflammation
Arteriosclerosis, thrombosis, & vascular biology. 2025 Oct 16;